1. Home
  2. List
Reference Patent

Reference - List

  • 80 Hits
  • Search Condition : Filter (MeSH = Carcinoma, Hepatocellular / metabolism*)
Species Resource Title
Human and Animal Cells HuCCT1(RCB1960) BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma.
Human and Animal Cells HuH-7 Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.
Human and Animal Cells Hep G2 Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner.
Human and Animal Cells Hep G2(RCB0459) Stimulation of apolipoprotein E secretion in human hepatoma Hep G2 cells by a cyclic acylpeptide, N-4909.
Human and Animal Cells HuH-7 Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.
Human and Animal Cells Hep G2(RCB1886) Dual-color fluorescence imaging to monitor CYP3A4 and CYP3A7 expression in human hepatic carcinoma HepG2 and HepaRG cells.
Human and Animal Cells HuH-6(RCB1367) , Hep G2 , HuH-7(RCB1366) SiRNA of frizzled-9 suppresses proliferation and motility of hepatoma cells.
Human and Animal Cells HuH-7(RCB1366) The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts.
Human and Animal Cells HuH-7(RCB1366) Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
Human and Animal Cells HuH-7 First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.
Human and Animal Cells Hep G2(RCB1648) , HuH-7(RCB1366) The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.
Human and Animal Cells HuH-7(RCB1366) Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Human and Animal Cells Hep G2 (-)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways.
Human and Animal Cells HuH-7(RCB1366) , Hep G2(RCB1886) CMTM6 Stabilizes PD-L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma.
Human and Animal Cells HuH-7 TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma.
Human and Animal Cells Hep G2 Bortezomib-resistance is associated with increased levels of proteasome subunits and apoptosis-avoidance.
Human and Animal Cells Hep G2(RCB1648) Development of biparatopic bispecific antibody possessing tetravalent scFv-Fc capable of binding to ROBO1 expressed in hepatocellular carcinoma cells.
Human and Animal Cells HuH-7 Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
Human and Animal Cells Hep G2(RCB1886) Comparative analysis of bilirubin glucuronidation activity in 2D- and 3D-cultured human hepatocellular carcinoma HepG2 cells.
Human and Animal Cells HuH-7 Downregulation of FOXP1 Inhibits Cell Proliferation in Hepatocellular Carcinoma by Inducing G1/S Phase Cell Cycle Arrest.